GARNIER VON C ET AL: "Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis" EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE LNKD- DOI:10.1002/1521-4141(200006)30:6<1638::AI D-IMMU1638>3.0.CO;2-R, vol. 30, no. 6, 1 June 2000 (2000-06-01), pages 1638-1645, XP002297947 ISSN: 0014-2980 (B1)

WO-A2-2008/098277 (B2)

PUROHIT A ET AL: "Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives" CLINICAL AND EXPERIMENTAL ALLERGY, vol. 38, no. 9, September 2008 (2008-09), pages 1514-1525, XP002595735 ISSN: 0954-7894 (B1)

VRTALA S ET AL: "Conversion of the major birch pollen allergen, bet v 1, into two nonanaphylactic T cell epitope-containing fragments: Candidates for a novel form of specific immunotherapy" JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US LNKD- DOI:10.1172/JCI119330, vol. 99, no. 7, 1 January 1997 (1997-01-01), pages 1673-1681, XP002221492 ISSN: 0021-9738 (B1)

VRTALA S ET AL: "GENETIC ENGINEERING OF RECOMBINANT HYPOALLERGENIC OLIGOMERS OF THE MAJOR BIRCH POLLEN ALLERGEN, BET V 1: CANDIDATES FOR SPECIFIC IMMUNOTHERAPY" INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, KARGER AG, CH LNKD- DOI:10.1159/000024075, vol. 118, no. 2-04, 1 February 1999 (1999-02-01), page 218/219, XP008027526 ISSN: 1018-2438 (B1)

WO-A2-2004/081028 (B1)

ELSAYED, H. ET AL: Int. Arch. Allergy Immunol., vol. 100, 1993, page 291, (B2)

EP-A1- 1 219 299 (B2)

GARNIER VON C, ET AL: "Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis", European Journal of Immunology, Wiley VCH, Weinheim, vol. 30, no. 6, 1 June 2000 (2000-06-01), pages 1638-1645, XP002297947, Weinheim ISSN: 0014-2980, DOI: 10.1002/1521-4141(200006)30:6<1638::AID-IM MU1638>3.0.CO;2-R (B2)

IPSEN ET AL: Clinical and Experimental Allergy, vol. 22, 1992, pages 391-399, (B2)

Ipsen H Et Al.: "epitopes of atopic allergens", Proceedings of Workshop, XIVth Congress of the European Academy of Allergy and Clinical Immunology Proceedings of Workshop, XIVth Congress of the European Academy of Allergy and Clinical Immunology, pages 3-8, XP055341165, Retrieved from the Internet: URL:file:///C:/Users/jk88286/Desktop/Java Printing.pdf [retrieved on 2017-02-01] (B2)

Jahn-Schmid, B. et al: "Bet v 1"1"4"2"-"1"5"6 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, vol. 116, no. 1, 1 July 2005 (2005-07-01), pages 213-219, XP004953875, AMSTERDAM, NL ISSN: 0091-6749, DOI: 10.1016/j.jaci.2005.04.019 (B2)

KELLNER ET AL: Journal of Allergy and Clinical Immunology, vol. 142, no. 2, August 2018 (2018-08), pages 678-680, (B2)

M. Focke, et al: "Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.", Clinical & Experimental Allergy : journal of the British Society for Allergy and Clinical Immunology, Wiley InterScience, UK, vol. 34, no. 10, 1 October 2004 (2004-10-01), pages 1525-1533, XP002657544, UK ISSN: 0954-7894, DOI: 10.1111/J.1365-2222.2004.02081.X (B2)

PELLATON, C. ET AL: Clinical and Translatinal Allergy, vol. 3, no. 17, 2013, pages 1-11, (B2)

SPANGFORT M D, ET AL.: "THREE-DIMENSIONAL STRUCTURE AND EPITOPES OF BET V 1", INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, KARGER AG, CH, vol. 113, no. 113, 1 January 1997 (1997-01-01), pages 243-245, XP002901971, CH ISSN: 1018-2438, DOI: 10.1159/000237559 (B2)

Spertini F. et al: "Allergen-specific immunotherapy of allergy and asthma: current and future trends", Expert review of respiratory medicine, Expert reviews, UK, vol. 3, no. 1, 6 February 2009 (2009-02-06), pages 37-51, XP009137087, UK ISSN: 1747-6356, DOI: 10.1586/17476348.3.1.37 (B2)

Spertini F. et al: Journal of Allergy and Clinical Immunology,, vol. 134, no. 1 , pages 239-240, (B2)

NIEDERBERGER V ET AL: "Vaccination with genetically engineered allergens prevents progression of allergic disease" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US LNKD- DOI:10.1073/PNAS.0404735101, vol. 101, no. SUPPL 2, 5 October 2004 (2004-10-05), pages 14677-14682, XP002373813 ISSN: 0027-8424 (B1)